The global Artificial Intelligence (AI) in Cancer market was valued at US$ 2405 million in 2025 and is anticipated to reach US$ 7980 million by 2032, at a CAGR of 18.6% from 2026 to 2032.

Artificial Intelligence (AI) in Cancer Market

Artificial Intelligence (AI) in Cancer refers to the application of machine learning, deep learning, and data-driven computational models across the oncology care continuum to support cancer screening, diagnosis, treatment planning, and outcome prediction. AI systems in oncology analyze large volumes of heterogeneous data, including medical imaging, digital pathology slides, genomic and multi-omics data, and real-world clinical records, to detect patterns that exceed human cognitive limits. In clinical practice, these solutions function primarily as decision-support tools, improving diagnostic accuracy, standardizing interpretation, accelerating workflows, and enabling more personalized treatment strategies. Rather than replacing oncologists, AI augments clinical expertise by reducing variability and supporting earlier and more consistent cancer detection and management.

From a multi-angle classification and parameterization perspective, the market can be segmented by clinical application stage (screening and early detection, diagnosis and classification, treatment planning, therapy monitoring, and prognosis), by data modality (imaging-based, pathology-based, genomics-based, clinical data-driven, or multimodal fusion), and by cancer type (lung, breast, colorectal, prostate, hematologic, and rare cancers). Additional parameters that differentiate solutions include sensitivity and specificity at defined clinical thresholds, explainability of AI outputs, integration with hospital IT systems, regulatory clearance status, and scalability across institutions and geographies.

The industry value chain begins upstream with data generation and infrastructure providers, including imaging equipment manufacturers, sequencing platforms, digital pathology scanners, and cloud computing services. Midstream players consist of AI oncology solution developers that curate datasets, train models, and package algorithms into regulated software or integrated platforms. Downstream customers include hospitals, cancer centers, diagnostic laboratories, pharmaceutical companies, and population-level screening programs, often adopting AI tools through enterprise licenses or software-as-a-service models.

From a profitability standpoint, AI in Cancer solutions typically exhibit gross margins in the 65–85% range, reflecting their software-centric economics once development and regulatory costs are absorbed. Cloud-based platforms and AI-as-a-service models tend to achieve the highest margins, while device-embedded solutions trade some margin for faster adoption through OEM partnerships. Market growth is driven by rising cancer incidence, shortages of oncology specialists, increasing data complexity, and the shift toward precision medicine. Key trends include multimodal data integration, expansion from detection to outcome prediction, deeper OEM and hospital integration, and growing use of AI to support value-based oncology care.

This report delivers a comprehensive overview of the global Artificial Intelligence (AI) in Cancer market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Artificial Intelligence (AI) in Cancer. The Artificial Intelligence (AI) in Cancer market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.

The report segments the global Artificial Intelligence (AI) in Cancer market comprehensively. Regional market sizes by Type, by Application, by AI Function Depth, and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.

This report will assist Artificial Intelligence (AI) in Cancer manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.

Market Segmentation

Scope of Artificial Intelligence (AI) in Cancer Market Report

Report Metric	Details
Report Name	Artificial Intelligence (AI) in Cancer Market
Accounted market size in 2025	US$ 2405 million
Forecasted market size in 2032	US$ 7980 million
CAGR	18.6%
Base Year	2025
Forecasted years	2026 - 2032
Segment by Type	Medical Imaging–based AI Digital Pathology–based AI Genomics & Multi-omics AI Others
Segment by AI Function Depth	Detection & Flagging Segmentation & Quantification Classification & Grading Prediction & Outcome Modeling Others
Segment by Product Form & Commercial Model	Device-embedded AI Systems Standalone Software / SaaS Platforms AI-as-a-Service for Oncology Others
Segment by Application	Lung Cancer Breast Cancer Colorectal & GI Cancers Prostate & Urological Cancers Hematologic & Rare Cancers Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	PathAI, PaigeAI, Lunit, INFERVISION TECHNOLOGY, Aidoc, VUNO, Inc., ANNALISE-AI PTY LTD, BioMind, YITU Technology, Shukun Technology, Beijing Huiyi Huiying Medical Technology, Shenzhen Keya Medical Technology, Densitas, Volpara, Niramai, MVision AI, MammoScreen, Perimeter Medical Imaging AI, ICAD, LungLifeAI, Nanox.AI, Varian Medical Systems, Canon Medical, GE Healthcare, Philips
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, by AI Function Depth, etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
Chapter 3: Provides a detailed view of the competitive landscape for Artificial Intelligence (AI) in Cancer companies, covering revenue share, development plans, and mergers and acquisitions.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
Chapter 12: Key findings and conclusions of the report.

FAQ for this report

How fast is Artificial Intelligence (AI) in Cancer Market growing?

Ans: The Artificial Intelligence (AI) in Cancer Market witnessing a CAGR of 18.6% during the forecast period 2026-2032.

What is the Artificial Intelligence (AI) in Cancer Market size in 2032?

Ans: The Artificial Intelligence (AI) in Cancer Market size in 2032 will be US$ 7980 million.

Who are the main players in the Artificial Intelligence (AI) in Cancer Market report?

Ans: The main players in the Artificial Intelligence (AI) in Cancer Market are PathAI, PaigeAI, Lunit, INFERVISION TECHNOLOGY, Aidoc, VUNO, Inc., ANNALISE-AI PTY LTD, BioMind, YITU Technology, Shukun Technology, Beijing Huiyi Huiying Medical Technology, Shenzhen Keya Medical Technology, Densitas, Volpara, Niramai, MVision AI, MammoScreen, Perimeter Medical Imaging AI, ICAD, LungLifeAI, Nanox.AI, Varian Medical Systems, Canon Medical, GE Healthcare, Philips

What are the Application segmentation covered in the Artificial Intelligence (AI) in Cancer Market report?

Ans: The Applications covered in the Artificial Intelligence (AI) in Cancer Market report are Lung Cancer, Breast Cancer, Colorectal & GI Cancers, Prostate & Urological Cancers, Hematologic & Rare Cancers, Others

What are the Type segmentation covered in the Artificial Intelligence (AI) in Cancer Market report?

Ans: The Types covered in the Artificial Intelligence (AI) in Cancer Market report are Medical Imaging–based AI, Digital Pathology–based AI, Genomics & Multi-omics AI, Others

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Artificial Intelligence (AI) in Cancer Market Size Growth Rate by Type: 2021 vs 2025 vs 2032

1.2.2 Medical Imaging–based AI

1.2.3 Digital Pathology–based AI

1.2.4 Genomics & Multi-omics AI

1.2.5 Others

1.3 Market by AI Function Depth

1.3.1 Global Artificial Intelligence (AI) in Cancer Market Size Growth Rate by AI Function Depth: 2021 vs 2025 vs 2032

1.3.2 Detection & Flagging

1.3.3 Segmentation & Quantification

1.3.4 Classification & Grading

1.3.5 Prediction & Outcome Modeling

1.3.6 Others

1.4 Market by Product Form & Commercial Model

1.4.1 Global Artificial Intelligence (AI) in Cancer Market Size Growth Rate by Product Form & Commercial Model: 2021 vs 2025 vs 2032

1.4.2 Device-embedded AI Systems

1.4.3 Standalone Software / SaaS Platforms

1.4.4 AI-as-a-Service for Oncology

1.4.5 Others

1.5 Market by Application

1.5.1 Global Artificial Intelligence (AI) in Cancer Market Growth by Application: 2021 vs 2025 vs 2032

1.5.2 Lung Cancer

1.5.3 Breast Cancer

1.5.4 Colorectal & GI Cancers

1.5.5 Prostate & Urological Cancers

1.5.6 Hematologic & Rare Cancers

1.5.7 Others

1.6 Assumptions and Limitations

1.7 Study Objectives

1.8 Years Considered

2 Global Growth Trends

2.1 Global Artificial Intelligence (AI) in Cancer Market Perspective (2021–2032)

2.2 Global Artificial Intelligence (AI) in Cancer Growth Trends by Region

2.2.1 Global Artificial Intelligence (AI) in Cancer Market Size by Region: 2021 vs 2025 vs 2032

2.2.2 Artificial Intelligence (AI) in Cancer Historic Market Size by Region (2021–2026)

2.2.3 Artificial Intelligence (AI) in Cancer Forecasted Market Size by Region (2027–2032)

2.3 Artificial Intelligence (AI) in Cancer Market Dynamics

2.3.1 Artificial Intelligence (AI) in Cancer Industry Trends

2.3.2 Artificial Intelligence (AI) in Cancer Market Drivers

2.3.3 Artificial Intelligence (AI) in Cancer Market Challenges

2.3.4 Artificial Intelligence (AI) in Cancer Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Artificial Intelligence (AI) in Cancer Players by Revenue

3.1.1 Global Top Artificial Intelligence (AI) in Cancer Players by Revenue (2021–2026)

3.1.2 Global Artificial Intelligence (AI) in Cancer Revenue Market Share by Players (2021–2026)

3.2 Global Top Artificial Intelligence (AI) in Cancer Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)

3.3 Global Key Players Ranking by Artificial Intelligence (AI) in Cancer Revenue

3.4 Global Artificial Intelligence (AI) in Cancer Market Concentration Ratio

3.4.1 Global Artificial Intelligence (AI) in Cancer Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Artificial Intelligence (AI) in Cancer Revenue in 2025

3.5 Global Key Players of Artificial Intelligence (AI) in Cancer Head Offices and Areas Served

3.6 Global Key Players of Artificial Intelligence (AI) in Cancer, Products and Applications

3.7 Global Key Players of Artificial Intelligence (AI) in Cancer, Date of General Availability (GA)

3.8 Mergers and Acquisitions, Expansion Plans

4 Artificial Intelligence (AI) in Cancer Breakdown Data by Type

4.1 Global Artificial Intelligence (AI) in Cancer Historic Market Size by Type (2021–2026)

4.2 Global Artificial Intelligence (AI) in Cancer Forecasted Market Size by Type (2027–2032)

5 Artificial Intelligence (AI) in Cancer Breakdown Data by Application

5.1 Global Artificial Intelligence (AI) in Cancer Historic Market Size by Application (2021–2026)

5.2 Global Artificial Intelligence (AI) in Cancer Forecasted Market Size by Application (2027–2032)

6 North America

6.1 North America Artificial Intelligence (AI) in Cancer Market Size (2021–2032)

6.2 North America Artificial Intelligence (AI) in Cancer Market Growth Rate by Country: 2021 vs 2025 vs 2032

6.3 North America Artificial Intelligence (AI) in Cancer Market Size by Country (2021–2026)

6.4 North America Artificial Intelligence (AI) in Cancer Market Size by Country (2027–2032)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Artificial Intelligence (AI) in Cancer Market Size (2021–2032)

7.2 Europe Artificial Intelligence (AI) in Cancer Market Growth Rate by Country: 2021 vs 2025 vs 2032

7.3 Europe Artificial Intelligence (AI) in Cancer Market Size by Country (2021–2026)

7.4 Europe Artificial Intelligence (AI) in Cancer Market Size by Country (2027–2032)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Ireland

8 Asia-Pacific

8.1 Asia-Pacific Artificial Intelligence (AI) in Cancer Market Size (2021–2032)

8.2 Asia-Pacific Artificial Intelligence (AI) in Cancer Market Growth Rate by Region: 2021 vs 2025 vs 2032

8.3 Asia-Pacific Artificial Intelligence (AI) in Cancer Market Size by Region (2021–2026)

8.4 Asia-Pacific Artificial Intelligence (AI) in Cancer Market Size by Region (2027–2032)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia & New Zealand

9 Latin America

9.1 Latin America Artificial Intelligence (AI) in Cancer Market Size (2021–2032)

9.2 Latin America Artificial Intelligence (AI) in Cancer Market Growth Rate by Country: 2021 vs 2025 vs 2032

9.3 Latin America Artificial Intelligence (AI) in Cancer Market Size by Country (2021–2026)

9.4 Latin America Artificial Intelligence (AI) in Cancer Market Size by Country (2027–2032)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Artificial Intelligence (AI) in Cancer Market Size (2021–2032)

10.2 Middle East & Africa Artificial Intelligence (AI) in Cancer Market Growth Rate by Country: 2021 vs 2025 vs 2032

10.3 Middle East & Africa Artificial Intelligence (AI) in Cancer Market Size by Country (2021–2026)

10.4 Middle East & Africa Artificial Intelligence (AI) in Cancer Market Size by Country (2027–2032)

10.5 Israel

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 PathAI

11.1.1 PathAI Company Details

11.1.2 PathAI Business Overview

11.1.3 PathAI Artificial Intelligence (AI) in Cancer Introduction

11.1.4 PathAI Revenue in Artificial Intelligence (AI) in Cancer Business (2021–2026)

11.1.5 PathAI Recent Development

11.2 PaigeAI

11.2.1 PaigeAI Company Details

11.2.2 PaigeAI Business Overview

11.2.3 PaigeAI Artificial Intelligence (AI) in Cancer Introduction

11.2.4 PaigeAI Revenue in Artificial Intelligence (AI) in Cancer Business (2021–2026)

11.2.5 PaigeAI Recent Development

11.3 Lunit

11.3.1 Lunit Company Details

11.3.2 Lunit Business Overview

11.3.3 Lunit Artificial Intelligence (AI) in Cancer Introduction

11.3.4 Lunit Revenue in Artificial Intelligence (AI) in Cancer Business (2021–2026)

11.3.5 Lunit Recent Development

11.4 INFERVISION TECHNOLOGY

11.4.1 INFERVISION TECHNOLOGY Company Details

11.4.2 INFERVISION TECHNOLOGY Business Overview

11.4.3 INFERVISION TECHNOLOGY Artificial Intelligence (AI) in Cancer Introduction

11.4.4 INFERVISION TECHNOLOGY Revenue in Artificial Intelligence (AI) in Cancer Business (2021–2026)

11.4.5 INFERVISION TECHNOLOGY Recent Development

11.5 Aidoc

11.5.1 Aidoc Company Details

11.5.2 Aidoc Business Overview

11.5.3 Aidoc Artificial Intelligence (AI) in Cancer Introduction

11.5.4 Aidoc Revenue in Artificial Intelligence (AI) in Cancer Business (2021–2026)

11.5.5 Aidoc Recent Development

11.6 VUNO, Inc.

11.6.1 VUNO, Inc. Company Details

11.6.2 VUNO, Inc. Business Overview

11.6.3 VUNO, Inc. Artificial Intelligence (AI) in Cancer Introduction

11.6.4 VUNO, Inc. Revenue in Artificial Intelligence (AI) in Cancer Business (2021–2026)

11.6.5 VUNO, Inc. Recent Development

11.7 ANNALISE-AI PTY LTD

11.7.1 ANNALISE-AI PTY LTD Company Details

11.7.2 ANNALISE-AI PTY LTD Business Overview

11.7.3 ANNALISE-AI PTY LTD Artificial Intelligence (AI) in Cancer Introduction

11.7.4 ANNALISE-AI PTY LTD Revenue in Artificial Intelligence (AI) in Cancer Business (2021–2026)

11.7.5 ANNALISE-AI PTY LTD Recent Development

11.8 BioMind

11.8.1 BioMind Company Details

11.8.2 BioMind Business Overview

11.8.3 BioMind Artificial Intelligence (AI) in Cancer Introduction

11.8.4 BioMind Revenue in Artificial Intelligence (AI) in Cancer Business (2021–2026)

11.8.5 BioMind Recent Development

11.9 YITU Technology

11.9.1 YITU Technology Company Details

11.9.2 YITU Technology Business Overview

11.9.3 YITU Technology Artificial Intelligence (AI) in Cancer Introduction

11.9.4 YITU Technology Revenue in Artificial Intelligence (AI) in Cancer Business (2021–2026)

11.9.5 YITU Technology Recent Development

11.10 Shukun Technology

11.10.1 Shukun Technology Company Details

11.10.2 Shukun Technology Business Overview

11.10.3 Shukun Technology Artificial Intelligence (AI) in Cancer Introduction

11.10.4 Shukun Technology Revenue in Artificial Intelligence (AI) in Cancer Business (2021–2026)

11.10.5 Shukun Technology Recent Development

11.11 Beijing Huiyi Huiying Medical Technology

11.11.1 Beijing Huiyi Huiying Medical Technology Company Details

11.11.2 Beijing Huiyi Huiying Medical Technology Business Overview

11.11.3 Beijing Huiyi Huiying Medical Technology Artificial Intelligence (AI) in Cancer Introduction

11.11.4 Beijing Huiyi Huiying Medical Technology Revenue in Artificial Intelligence (AI) in Cancer Business (2021–2026)

11.11.5 Beijing Huiyi Huiying Medical Technology Recent Development

11.12 Shenzhen Keya Medical Technology

11.12.1 Shenzhen Keya Medical Technology Company Details

11.12.2 Shenzhen Keya Medical Technology Business Overview

11.12.3 Shenzhen Keya Medical Technology Artificial Intelligence (AI) in Cancer Introduction

11.12.4 Shenzhen Keya Medical Technology Revenue in Artificial Intelligence (AI) in Cancer Business (2021–2026)

11.12.5 Shenzhen Keya Medical Technology Recent Development

11.13 Densitas

11.13.1 Densitas Company Details

11.13.2 Densitas Business Overview

11.13.3 Densitas Artificial Intelligence (AI) in Cancer Introduction

11.13.4 Densitas Revenue in Artificial Intelligence (AI) in Cancer Business (2021–2026)

11.13.5 Densitas Recent Development

11.14 Volpara

11.14.1 Volpara Company Details

11.14.2 Volpara Business Overview

11.14.3 Volpara Artificial Intelligence (AI) in Cancer Introduction

11.14.4 Volpara Revenue in Artificial Intelligence (AI) in Cancer Business (2021–2026)

11.14.5 Volpara Recent Development

11.15 Niramai

11.15.1 Niramai Company Details

11.15.2 Niramai Business Overview

11.15.3 Niramai Artificial Intelligence (AI) in Cancer Introduction

11.15.4 Niramai Revenue in Artificial Intelligence (AI) in Cancer Business (2021–2026)

11.15.5 Niramai Recent Development

11.16 MVision AI

11.16.1 MVision AI Company Details

11.16.2 MVision AI Business Overview

11.16.3 MVision AI Artificial Intelligence (AI) in Cancer Introduction

11.16.4 MVision AI Revenue in Artificial Intelligence (AI) in Cancer Business (2021–2026)

11.16.5 MVision AI Recent Development

11.17 MammoScreen

11.17.1 MammoScreen Company Details

11.17.2 MammoScreen Business Overview

11.17.3 MammoScreen Artificial Intelligence (AI) in Cancer Introduction

11.17.4 MammoScreen Revenue in Artificial Intelligence (AI) in Cancer Business (2021–2026)

11.17.5 MammoScreen Recent Development

11.18 Perimeter Medical Imaging AI

11.18.1 Perimeter Medical Imaging AI Company Details

11.18.2 Perimeter Medical Imaging AI Business Overview

11.18.3 Perimeter Medical Imaging AI Artificial Intelligence (AI) in Cancer Introduction

11.18.4 Perimeter Medical Imaging AI Revenue in Artificial Intelligence (AI) in Cancer Business (2021–2026)

11.18.5 Perimeter Medical Imaging AI Recent Development

11.19 ICAD

11.19.1 ICAD Company Details

11.19.2 ICAD Business Overview

11.19.3 ICAD Artificial Intelligence (AI) in Cancer Introduction

11.19.4 ICAD Revenue in Artificial Intelligence (AI) in Cancer Business (2021–2026)

11.19.5 ICAD Recent Development

11.20 LungLifeAI

11.20.1 LungLifeAI Company Details

11.20.2 LungLifeAI Business Overview

11.20.3 LungLifeAI Artificial Intelligence (AI) in Cancer Introduction

11.20.4 LungLifeAI Revenue in Artificial Intelligence (AI) in Cancer Business (2021–2026)

11.20.5 LungLifeAI Recent Development

11.21 Nanox.AI

11.21.1 Nanox.AI Company Details

11.21.2 Nanox.AI Business Overview

11.21.3 Nanox.AI Artificial Intelligence (AI) in Cancer Introduction

11.21.4 Nanox.AI Revenue in Artificial Intelligence (AI) in Cancer Business (2021–2026)

11.21.5 Nanox.AI Recent Development

11.22 Varian Medical Systems

11.22.1 Varian Medical Systems Company Details

11.22.2 Varian Medical Systems Business Overview

11.22.3 Varian Medical Systems Artificial Intelligence (AI) in Cancer Introduction

11.22.4 Varian Medical Systems Revenue in Artificial Intelligence (AI) in Cancer Business (2021–2026)

11.22.5 Varian Medical Systems Recent Development

11.23 Canon Medical

11.23.1 Canon Medical Company Details

11.23.2 Canon Medical Business Overview

11.23.3 Canon Medical Artificial Intelligence (AI) in Cancer Introduction

11.23.4 Canon Medical Revenue in Artificial Intelligence (AI) in Cancer Business (2021–2026)

11.23.5 Canon Medical Recent Development

11.24 GE Healthcare

11.24.1 GE Healthcare Company Details

11.24.2 GE Healthcare Business Overview

11.24.3 GE Healthcare Artificial Intelligence (AI) in Cancer Introduction

11.24.4 GE Healthcare Revenue in Artificial Intelligence (AI) in Cancer Business (2021–2026)

11.24.5 GE Healthcare Recent Development

11.25 Philips

11.25.1 Philips Company Details

11.25.2 Philips Business Overview

11.25.3 Philips Artificial Intelligence (AI) in Cancer Introduction

11.25.4 Philips Revenue in Artificial Intelligence (AI) in Cancer Business (2021–2026)

11.25.5 Philips Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

GE Healthcare

Varian Medical Systems

Niramai

Densitas

MammoScreen

MVision AI

Volpara

LungLifeAI

PathAI

PaigeAI

Lunit

Infervision Technology

Beijing Huiyi Huiying Medical Technology

Shenzhen Keya Medical Technology

Perimeter Medical Imaging AI

List of Tables

Table 1. Global Artificial Intelligence (AI) in Cancer Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032

Table 2. Key Players of Medical Imaging–based AI

Table 3. Key Players of Digital Pathology–based AI

Table 4. Key Players of Genomics & Multi-omics AI

Table 5. Key Players of Others

Table 6. Global Artificial Intelligence (AI) in Cancer Market Size Growth Rate by AI Function Depth (US$ Million): 2021 vs 2025 vs 2032

Table 7. Key Players of Detection & Flagging

Table 8. Key Players of Segmentation & Quantification

Table 9. Key Players of Classification & Grading

Table 10. Key Players of Prediction & Outcome Modeling

Table 11. Key Players of Others

Table 12. Global Artificial Intelligence (AI) in Cancer Market Size Growth Rate by Product Form & Commercial Model (US$ Million): 2021 vs 2025 vs 2032

Table 13. Key Players of Device-embedded AI Systems

Table 14. Key Players of Standalone Software / SaaS Platforms

Table 15. Key Players of AI-as-a-Service for Oncology

Table 16. Key Players of Others

Table 17. Global Artificial Intelligence (AI) in Cancer Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032

Table 18. Global Artificial Intelligence (AI) in Cancer Market Size by Region (US$ Million): 2021 vs 2025 vs 2032

Table 19. Global Artificial Intelligence (AI) in Cancer Market Size by Region (US$ Million), 2021–2026

Table 20. Global Artificial Intelligence (AI) in Cancer Market Share by Region (2021–2026)

Table 21. Global Artificial Intelligence (AI) in Cancer Forecasted Market Size by Region (US$ Million), 2027–2032

Table 22. Global Artificial Intelligence (AI) in Cancer Market Share by Region (2027–2032)

Table 23. Artificial Intelligence (AI) in Cancer Market Trends

Table 24. Artificial Intelligence (AI) in Cancer Market Drivers

Table 25. Artificial Intelligence (AI) in Cancer Market Challenges

Table 26. Artificial Intelligence (AI) in Cancer Market Restraints

Table 27. Global Artificial Intelligence (AI) in Cancer Revenue by Players (US$ Million), 2021–2026

Table 28. Global Artificial Intelligence (AI) in Cancer Market Share by Players (2021–2026)

Table 29. Global Top Artificial Intelligence (AI) in Cancer Players by Tier (Tier 1, Tier 2, and Tier 3), based on Artificial Intelligence (AI) in Cancer Revenue, 2025

Table 30. Ranking of Global Top Artificial Intelligence (AI) in Cancer Companies by Revenue (US$ Million) in 2025

Table 31. Global 5 Largest Players Market Share by Artificial Intelligence (AI) in Cancer Revenue (CR5 and HHI), 2021–2026

Table 32. Global Key Players of Artificial Intelligence (AI) in Cancer, Headquarters and Area Served

Table 33. Global Key Players of Artificial Intelligence (AI) in Cancer, Products and Applications

Table 34. Global Key Players of Artificial Intelligence (AI) in Cancer, Date of General Availability (GA)

Table 35. Mergers and Acquisitions, Expansion Plans

Table 36. Global Artificial Intelligence (AI) in Cancer Market Size by Type (US$ Million), 2021–2026

Table 37. Global Artificial Intelligence (AI) in Cancer Revenue Market Share by Type (2021–2026)

Table 38. Global Artificial Intelligence (AI) in Cancer Forecasted Market Size by Type (US$ Million), 2027–2032

Table 39. Global Artificial Intelligence (AI) in Cancer Revenue Market Share by Type (2027–2032)

Table 40. Global Artificial Intelligence (AI) in Cancer Market Size by Application (US$ Million), 2021–2026

Table 41. Global Artificial Intelligence (AI) in Cancer Revenue Market Share by Application (2021–2026)

Table 42. Global Artificial Intelligence (AI) in Cancer Forecasted Market Size by Application (US$ Million), 2027–2032

Table 43. Global Artificial Intelligence (AI) in Cancer Revenue Market Share by Application (2027–2032)

Table 44. North America Artificial Intelligence (AI) in Cancer Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 45. North America Artificial Intelligence (AI) in Cancer Market Size by Country (US$ Million), 2021–2026

Table 46. North America Artificial Intelligence (AI) in Cancer Market Size by Country (US$ Million), 2027–2032

Table 47. Europe Artificial Intelligence (AI) in Cancer Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 48. Europe Artificial Intelligence (AI) in Cancer Market Size by Country (US$ Million), 2021–2026

Table 49. Europe Artificial Intelligence (AI) in Cancer Market Size by Country (US$ Million), 2027–2032

Table 50. Asia-Pacific Artificial Intelligence (AI) in Cancer Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032

Table 51. Asia-Pacific Artificial Intelligence (AI) in Cancer Market Size by Region (US$ Million), 2021–2026

Table 52. Asia-Pacific Artificial Intelligence (AI) in Cancer Market Size by Region (US$ Million), 2027–2032

Table 53. Latin America Artificial Intelligence (AI) in Cancer Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 54. Latin America Artificial Intelligence (AI) in Cancer Market Size by Country (US$ Million), 2021–2026

Table 55. Latin America Artificial Intelligence (AI) in Cancer Market Size by Country (US$ Million), 2027–2032

Table 56. Middle East & Africa Artificial Intelligence (AI) in Cancer Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 57. Middle East & Africa Artificial Intelligence (AI) in Cancer Market Size by Country (US$ Million), 2021–2026

Table 58. Middle East & Africa Artificial Intelligence (AI) in Cancer Market Size by Country (US$ Million), 2027–2032

Table 59. PathAI Company Details

Table 60. PathAI Business Overview

Table 61. PathAI Artificial Intelligence (AI) in Cancer Product

Table 62. PathAI Revenue in Artificial Intelligence (AI) in Cancer Business (US$ Million), 2021–2026

Table 63. PathAI Recent Development

Table 64. PaigeAI Company Details

Table 65. PaigeAI Business Overview

Table 66. PaigeAI Artificial Intelligence (AI) in Cancer Product

Table 67. PaigeAI Revenue in Artificial Intelligence (AI) in Cancer Business (US$ Million), 2021–2026

Table 68. PaigeAI Recent Development

Table 69. Lunit Company Details

Table 70. Lunit Business Overview

Table 71. Lunit Artificial Intelligence (AI) in Cancer Product

Table 72. Lunit Revenue in Artificial Intelligence (AI) in Cancer Business (US$ Million), 2021–2026

Table 73. Lunit Recent Development

Table 74. INFERVISION TECHNOLOGY Company Details

Table 75. INFERVISION TECHNOLOGY Business Overview

Table 76. INFERVISION TECHNOLOGY Artificial Intelligence (AI) in Cancer Product

Table 77. INFERVISION TECHNOLOGY Revenue in Artificial Intelligence (AI) in Cancer Business (US$ Million), 2021–2026

Table 78. INFERVISION TECHNOLOGY Recent Development

Table 79. Aidoc Company Details

Table 80. Aidoc Business Overview

Table 81. Aidoc Artificial Intelligence (AI) in Cancer Product

Table 82. Aidoc Revenue in Artificial Intelligence (AI) in Cancer Business (US$ Million), 2021–2026

Table 83. Aidoc Recent Development

Table 84. VUNO, Inc. Company Details

Table 85. VUNO, Inc. Business Overview

Table 86. VUNO, Inc. Artificial Intelligence (AI) in Cancer Product

Table 87. VUNO, Inc. Revenue in Artificial Intelligence (AI) in Cancer Business (US$ Million), 2021–2026

Table 88. VUNO, Inc. Recent Development

Table 89. ANNALISE-AI PTY LTD Company Details

Table 90. ANNALISE-AI PTY LTD Business Overview

Table 91. ANNALISE-AI PTY LTD Artificial Intelligence (AI) in Cancer Product

Table 92. ANNALISE-AI PTY LTD Revenue in Artificial Intelligence (AI) in Cancer Business (US$ Million), 2021–2026

Table 93. ANNALISE-AI PTY LTD Recent Development

Table 94. BioMind Company Details

Table 95. BioMind Business Overview

Table 96. BioMind Artificial Intelligence (AI) in Cancer Product

Table 97. BioMind Revenue in Artificial Intelligence (AI) in Cancer Business (US$ Million), 2021–2026

Table 98. BioMind Recent Development

Table 99. YITU Technology Company Details

Table 100. YITU Technology Business Overview

Table 101. YITU Technology Artificial Intelligence (AI) in Cancer Product

Table 102. YITU Technology Revenue in Artificial Intelligence (AI) in Cancer Business (US$ Million), 2021–2026

Table 103. YITU Technology Recent Development

Table 104. Shukun Technology Company Details

Table 105. Shukun Technology Business Overview

Table 106. Shukun Technology Artificial Intelligence (AI) in Cancer Product

Table 107. Shukun Technology Revenue in Artificial Intelligence (AI) in Cancer Business (US$ Million), 2021–2026

Table 108. Shukun Technology Recent Development

Table 109. Beijing Huiyi Huiying Medical Technology Company Details

Table 110. Beijing Huiyi Huiying Medical Technology Business Overview

Table 111. Beijing Huiyi Huiying Medical Technology Artificial Intelligence (AI) in Cancer Product

Table 112. Beijing Huiyi Huiying Medical Technology Revenue in Artificial Intelligence (AI) in Cancer Business (US$ Million), 2021–2026

Table 113. Beijing Huiyi Huiying Medical Technology Recent Development

Table 114. Shenzhen Keya Medical Technology Company Details

Table 115. Shenzhen Keya Medical Technology Business Overview

Table 116. Shenzhen Keya Medical Technology Artificial Intelligence (AI) in Cancer Product

Table 117. Shenzhen Keya Medical Technology Revenue in Artificial Intelligence (AI) in Cancer Business (US$ Million), 2021–2026

Table 118. Shenzhen Keya Medical Technology Recent Development

Table 119. Densitas Company Details

Table 120. Densitas Business Overview

Table 121. Densitas Artificial Intelligence (AI) in Cancer Product

Table 122. Densitas Revenue in Artificial Intelligence (AI) in Cancer Business (US$ Million), 2021–2026

Table 123. Densitas Recent Development

Table 124. Volpara Company Details

Table 125. Volpara Business Overview

Table 126. Volpara Artificial Intelligence (AI) in Cancer Product

Table 127. Volpara Revenue in Artificial Intelligence (AI) in Cancer Business (US$ Million), 2021–2026

Table 128. Volpara Recent Development

Table 129. Niramai Company Details

Table 130. Niramai Business Overview

Table 131. Niramai Artificial Intelligence (AI) in Cancer Product

Table 132. Niramai Revenue in Artificial Intelligence (AI) in Cancer Business (US$ Million), 2021–2026

Table 133. Niramai Recent Development

Table 134. MVision AI Company Details

Table 135. MVision AI Business Overview

Table 136. MVision AI Artificial Intelligence (AI) in Cancer Product

Table 137. MVision AI Revenue in Artificial Intelligence (AI) in Cancer Business (US$ Million), 2021–2026

Table 138. MVision AI Recent Development

Table 139. MammoScreen Company Details

Table 140. MammoScreen Business Overview

Table 141. MammoScreen Artificial Intelligence (AI) in Cancer Product

Table 142. MammoScreen Revenue in Artificial Intelligence (AI) in Cancer Business (US$ Million), 2021–2026

Table 143. MammoScreen Recent Development

Table 144. Perimeter Medical Imaging AI Company Details

Table 145. Perimeter Medical Imaging AI Business Overview

Table 146. Perimeter Medical Imaging AI Artificial Intelligence (AI) in Cancer Product

Table 147. Perimeter Medical Imaging AI Revenue in Artificial Intelligence (AI) in Cancer Business (US$ Million), 2021–2026

Table 148. Perimeter Medical Imaging AI Recent Development

Table 149. ICAD Company Details

Table 150. ICAD Business Overview

Table 151. ICAD Artificial Intelligence (AI) in Cancer Product

Table 152. ICAD Revenue in Artificial Intelligence (AI) in Cancer Business (US$ Million), 2021–2026

Table 153. ICAD Recent Development

Table 154. LungLifeAI Company Details

Table 155. LungLifeAI Business Overview

Table 156. LungLifeAI Artificial Intelligence (AI) in Cancer Product

Table 157. LungLifeAI Revenue in Artificial Intelligence (AI) in Cancer Business (US$ Million), 2021–2026

Table 158. LungLifeAI Recent Development

Table 159. Nanox.AI Company Details

Table 160. Nanox.AI Business Overview

Table 161. Nanox.AI Artificial Intelligence (AI) in Cancer Product

Table 162. Nanox.AI Revenue in Artificial Intelligence (AI) in Cancer Business (US$ Million), 2021–2026

Table 163. Nanox.AI Recent Development

Table 164. Varian Medical Systems Company Details

Table 165. Varian Medical Systems Business Overview

Table 166. Varian Medical Systems Artificial Intelligence (AI) in Cancer Product

Table 167. Varian Medical Systems Revenue in Artificial Intelligence (AI) in Cancer Business (US$ Million), 2021–2026

Table 168. Varian Medical Systems Recent Development

Table 169. Canon Medical Company Details

Table 170. Canon Medical Business Overview

Table 171. Canon Medical Artificial Intelligence (AI) in Cancer Product

Table 172. Canon Medical Revenue in Artificial Intelligence (AI) in Cancer Business (US$ Million), 2021–2026

Table 173. Canon Medical Recent Development

Table 174. GE Healthcare Company Details

Table 175. GE Healthcare Business Overview

Table 176. GE Healthcare Artificial Intelligence (AI) in Cancer Product

Table 177. GE Healthcare Revenue in Artificial Intelligence (AI) in Cancer Business (US$ Million), 2021–2026

Table 178. GE Healthcare Recent Development

Table 179. Philips Company Details

Table 180. Philips Business Overview

Table 181. Philips Artificial Intelligence (AI) in Cancer Product

Table 182. Philips Revenue in Artificial Intelligence (AI) in Cancer Business (US$ Million), 2021–2026

Table 183. Philips Recent Development

Table 184. Research Programs/Design for This Report

Table 185. Key Data Information from Secondary Sources

Table 186. Key Data Information from Primary Sources

Table 187. Authors List of This Report

List of Figures

Figure 1. Artificial Intelligence (AI) in Cancer Picture

Figure 2. Global Artificial Intelligence (AI) in Cancer Market Size Comparison by Type (US$ Million), 2021–2032

Figure 3. Global Artificial Intelligence (AI) in Cancer Market Share by Type: 2025 vs 2032

Figure 4. Medical Imaging–based AI Features

Figure 5. Digital Pathology–based AI Features

Figure 6. Genomics & Multi-omics AI Features

Figure 7. Others Features

Figure 8. Global Artificial Intelligence (AI) in Cancer Market Size Comparison by AI Function Depth (US$ Million), 2021–2032

Figure 9. Detection & Flagging Features

Figure 10. Segmentation & Quantification Features

Figure 11. Classification & Grading Features

Figure 12. Prediction & Outcome Modeling Features

Figure 13. Others Features

Figure 14. Global Artificial Intelligence (AI) in Cancer Market Size Comparison by Product Form & Commercial Model (US$ Million), 2021–2032

Figure 15. Device-embedded AI Systems Features

Figure 16. Standalone Software / SaaS Platforms Features

Figure 17. AI-as-a-Service for Oncology Features

Figure 18. Others Features

Figure 19. Global Artificial Intelligence (AI) in Cancer Market Size by Application (US$ Million), 2021–2032

Figure 20. Global Artificial Intelligence (AI) in Cancer Market Share by Application: 2025 vs 2032

Figure 21. Lung Cancer Case Studies

Figure 22. Breast Cancer Case Studies

Figure 23. Colorectal & GI Cancers Case Studies

Figure 24. Prostate & Urological Cancers Case Studies

Figure 25. Hematologic & Rare Cancers Case Studies

Figure 26. Others Case Studies

Figure 27. Artificial Intelligence (AI) in Cancer Report Years Considered

Figure 28. Global Artificial Intelligence (AI) in Cancer Market Size (US$ Million), Year-over-Year: 2021–2032

Figure 29. Global Artificial Intelligence (AI) in Cancer Market Size, (US$ Million), 2021 vs 2025 vs 2032

Figure 30. Global Artificial Intelligence (AI) in Cancer Market Share by Region: 2025 vs 2032

Figure 31. Global Artificial Intelligence (AI) in Cancer Market Share by Players in 2025

Figure 32. Global Artificial Intelligence (AI) in Cancer Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

Figure 33. The Top 10 and 5 Players Market Share by Artificial Intelligence (AI) in Cancer Revenue in 2025

Figure 34. North America Artificial Intelligence (AI) in Cancer Market Size YoY Growth (US$ Million), 2021–2032

Figure 35. North America Artificial Intelligence (AI) in Cancer Market Share by Country (2021–2032)

Figure 36. United States Artificial Intelligence (AI) in Cancer Market Size YoY Growth (US$ Million), 2021–2032

Figure 37. Canada Artificial Intelligence (AI) in Cancer Market Size YoY Growth (US$ Million), 2021–2032

Figure 38. Europe Artificial Intelligence (AI) in Cancer Market Size YoY Growth (US$ Million), 2021–2032

Figure 39. Europe Artificial Intelligence (AI) in Cancer Market Share by Country (2021–2032)

Figure 40. Germany Artificial Intelligence (AI) in Cancer Market Size YoY Growth (US$ Million), 2021–2032

Figure 41. France Artificial Intelligence (AI) in Cancer Market Size YoY Growth (US$ Million), 2021–2032

Figure 42. U.K. Artificial Intelligence (AI) in Cancer Market Size YoY Growth (US$ Million), 2021–2032

Figure 43. Italy Artificial Intelligence (AI) in Cancer Market Size YoY Growth (US$ Million), 2021–2032

Figure 44. Russia Artificial Intelligence (AI) in Cancer Market Size YoY Growth (US$ Million), 2021–2032

Figure 45. Ireland Artificial Intelligence (AI) in Cancer Market Size YoY Growth (US$ Million), 2021–2032

Figure 46. Asia-Pacific Artificial Intelligence (AI) in Cancer Market Size YoY Growth (US$ Million), 2021–2032

Figure 47. Asia-Pacific Artificial Intelligence (AI) in Cancer Market Share by Region (2021–2032)

Figure 48. China Artificial Intelligence (AI) in Cancer Market Size YoY Growth (US$ Million), 2021–2032

Figure 49. Japan Artificial Intelligence (AI) in Cancer Market Size YoY Growth (US$ Million), 2021–2032

Figure 50. South Korea Artificial Intelligence (AI) in Cancer Market Size YoY Growth (US$ Million), 2021–2032

Figure 51. Southeast Asia Artificial Intelligence (AI) in Cancer Market Size YoY Growth (US$ Million), 2021–2032

Figure 52. India Artificial Intelligence (AI) in Cancer Market Size YoY Growth (US$ Million), 2021–2032

Figure 53. Australia & New Zealand Artificial Intelligence (AI) in Cancer Market Size YoY Growth (US$ Million), 2021–2032

Figure 54. Latin America Artificial Intelligence (AI) in Cancer Market Size YoY Growth (US$ Million), 2021–2032

Figure 55. Latin America Artificial Intelligence (AI) in Cancer Market Share by Country (2021–2032)

Figure 56. Mexico Artificial Intelligence (AI) in Cancer Market Size YoY Growth (US$ Million), 2021–2032

Figure 57. Brazil Artificial Intelligence (AI) in Cancer Market Size YoY Growth (US$ Million), 2021–2032

Figure 58. Middle East & Africa Artificial Intelligence (AI) in Cancer Market Size YoY Growth (US$ Million), 2021–2032

Figure 59. Middle East & Africa Artificial Intelligence (AI) in Cancer Market Share by Country (2021–2032)

Figure 60. Israel Artificial Intelligence (AI) in Cancer Market Size YoY Growth (US$ Million), 2021–2032

Figure 61. Saudi Arabia Artificial Intelligence (AI) in Cancer Market Size YoY Growth (US$ Million), 2021–2032

Figure 62. UAE Artificial Intelligence (AI) in Cancer Market Size YoY Growth (US$ Million), 2021–2032

Figure 63. PathAI Revenue Growth Rate in Artificial Intelligence (AI) in Cancer Business (2021–2026)

Figure 64. PaigeAI Revenue Growth Rate in Artificial Intelligence (AI) in Cancer Business (2021–2026)

Figure 65. Lunit Revenue Growth Rate in Artificial Intelligence (AI) in Cancer Business (2021–2026)

Figure 66. INFERVISION TECHNOLOGY Revenue Growth Rate in Artificial Intelligence (AI) in Cancer Business (2021–2026)

Figure 67. Aidoc Revenue Growth Rate in Artificial Intelligence (AI) in Cancer Business (2021–2026)

Figure 68. VUNO, Inc. Revenue Growth Rate in Artificial Intelligence (AI) in Cancer Business (2021–2026)

Figure 69. ANNALISE-AI PTY LTD Revenue Growth Rate in Artificial Intelligence (AI) in Cancer Business (2021–2026)

Figure 70. BioMind Revenue Growth Rate in Artificial Intelligence (AI) in Cancer Business (2021–2026)

Figure 71. YITU Technology Revenue Growth Rate in Artificial Intelligence (AI) in Cancer Business (2021–2026)

Figure 72. Shukun Technology Revenue Growth Rate in Artificial Intelligence (AI) in Cancer Business (2021–2026)

Figure 73. Beijing Huiyi Huiying Medical Technology Revenue Growth Rate in Artificial Intelligence (AI) in Cancer Business (2021–2026)

Figure 74. Shenzhen Keya Medical Technology Revenue Growth Rate in Artificial Intelligence (AI) in Cancer Business (2021–2026)

Figure 75. Densitas Revenue Growth Rate in Artificial Intelligence (AI) in Cancer Business (2021–2026)

Figure 76. Volpara Revenue Growth Rate in Artificial Intelligence (AI) in Cancer Business (2021–2026)

Figure 77. Niramai Revenue Growth Rate in Artificial Intelligence (AI) in Cancer Business (2021–2026)

Figure 78. MVision AI Revenue Growth Rate in Artificial Intelligence (AI) in Cancer Business (2021–2026)

Figure 79. MammoScreen Revenue Growth Rate in Artificial Intelligence (AI) in Cancer Business (2021–2026)

Figure 80. Perimeter Medical Imaging AI Revenue Growth Rate in Artificial Intelligence (AI) in Cancer Business (2021–2026)

Figure 81. ICAD Revenue Growth Rate in Artificial Intelligence (AI) in Cancer Business (2021–2026)

Figure 82. LungLifeAI Revenue Growth Rate in Artificial Intelligence (AI) in Cancer Business (2021–2026)

Figure 83. Nanox.AI Revenue Growth Rate in Artificial Intelligence (AI) in Cancer Business (2021–2026)

Figure 84. Varian Medical Systems Revenue Growth Rate in Artificial Intelligence (AI) in Cancer Business (2021–2026)

Figure 85. Canon Medical Revenue Growth Rate in Artificial Intelligence (AI) in Cancer Business (2021–2026)

Figure 86. GE Healthcare Revenue Growth Rate in Artificial Intelligence (AI) in Cancer Business (2021–2026)

Figure 87. Philips Revenue Growth Rate in Artificial Intelligence (AI) in Cancer Business (2021–2026)

Figure 88. Bottom-up and Top-down Approaches for This Report

Figure 89. Data Triangulation

Figure 90. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic

$2900

Single User License

Multi User

Electronic

$4350

Multi User License

Enterprise License

Electronic

$5800

Enterprise License

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Artificial Intelligence AI in Oncology Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global AI Tools for Cancer Therapy Market Research Report 2024

Global Artificial Intelligence in Radiology Market Research Report 2024

Medical AI Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global AI Technology in Healthcare Market Research Report 2024

Global AI In Clinical Trials Market Research Report 2024

Healthcare Artificial Intelligence Market

Global AI powered Cancer Diagnostic Tool Market Research Report 2025

Global AI in Medical Robotics Market Research Report 2024

Global Intelligent Clinical Trials Market Research Report 2024

Global Artificial Intelligence in Drug Discovery Market Size Status and Forecast 2020 2026

AI based Clinical Trial Solution Market

Artificial Intelligence in Diagnostics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Artificial Intelligence AI in Drug Discovery Market Insights Forecast to 2030

Global Artificial Intelligence in the Operating Room Market Research Report 2025

Global Radiology AI Market Insights Forecast to 2030

Global Artificial Intelligence Systems in Healthcare Market Insights Forecast to 2030

Global Artificial Intelligence in Medical Market Research Report 2025

Artificial Intelligence In Breast Imaging Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions